HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 238.16 billion as of January 16, 2026. Its market cap has decreased by -27.52% in one year.

Market Cap

238.16B

Enterprise Value

228.50B

Revenue

36.10B

Ranking

n/a

PE Ratio

503.87

Stock Price

16,960.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 238.16B, an increase of 182.58%. That is a compound annual growth rate of 10.85%.

Market Cap History

Date	Market Cap	% Change
Jan 19, 2026	238.16B	5.74%
Dec 30, 2025	225.24B	-33.44%
Dec 30, 2024	338.42B	58.45%
Dec 28, 2023	213.58B	43.49%
Dec 29, 2022	148.85B	-21.48%
Dec 30, 2021	189.57B	-21.05%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	90.13T
Celltrion	45.73T
ALTEOGEN	27.70T
ABL Bio	10.89T
SK Biopharmaceuticals	9.43T
Yuhan	8.05T
HLB Co., Ltd.	6.97T
Sam Chun Dang Pharm.	6.49T

Market Cap Rankings